DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Psoriasis | Treatment Algorithms: Claims Data Analysis | Pediatric Psoriasis | US | 2022
Psoriasis is a chronic, inflammatory autoimmune skin disease that can affect children, adolescents, and adults. Although adult psoriasis and pediatric psoriasis are similar, effective management of…
Hepatocellular Carcinoma – Unmet Need – Unmet Need – Advanced Hepatocellular Carcinoma (US/EU5)
Hepatocellular carcinoma, the most common type of liver cancer, occurs as a result of chronic liver cirrhosis. It has a five-year survival rate of only 18%. First-line advanced hepatocellular…
Asthma | Treatment Algorithms: Claims Data Analysis | Pediatric Asthma | US | 2022
Pediatric asthma is treated using two types of pharmacotherapies: rescue therapy for acute symptoms via bronchodilation (e.g., a SABA such as Teva’s ProAir HFA) and maintenance therapy to prevent…
Congenital Heart Block – Executive Insights – Congenital Heart Block | Executive Insights | US/EU5 | 2022
Congenital heart block (CHB), also known as atrioventricular block, is a rare heart block disorder in which maternal antibodies attack the impulse-generating heart muscles of fetuses and newborns…
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) – Executive Insights – Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Executive Insights | US/EU5 | 2022
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disorder caused by inflammation and demyelination of the peripheral nerves characterized by weakness associated with loss of…
Bullous Pemphigoid – Executive Insights – Bullous Pemphigoid | Executive Insights | US/EU5 | 2022
Bullous pemphigoid (BP) is the most common type of subepidermal autoimmune bullous diseases, which characteristically affects the elderly and is seen mainly in patients older than 60. The disease…
Inflammatory Myositis – Executive Insights – Inflammatory Myositis: Executive Insights | US/EU5 | 2022
Inflammatory myositis (IM) is a heterogeneous group of autoimmune disorders characterized by immune-mediated muscle injury that results in muscle inflammation and skeletal muscle weakness…
Hemolytic Disease of the Fetus and Newborn – Executive Insights – Hemolytic Disease of the Fetus and Newborn | Executive Insights | US/EU5
Hemolytic disease of the fetus and newborn (HDFN), also known as alloimmune HDFN or erythroblastosis fetalis, is a rare red blood cell disorder in which maternal antibodies attack the red blood…
Fetal and Neonatal Alloimmune Thrombocytopenia – Executive Insights – Fetal and Neonatal Alloimmune Thrombocytopenia | Executive Insights | US/EU5
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare, alloimmune thrombocytopenic disorder affecting fetuses / neonates, characterized in severe cases by intracranial hemorrhage. It can…
Chronic Heart Failure | Reduced Ejection Fraction | Treatment Algorithms | Claims Data Analysis | US | 2022
Although heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all chronic heart failure cases and even though our understanding of the disease’s…
